Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor
- 1 December 1996
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (14) , 2467-2473
- https://doi.org/10.1016/s0959-8049(96)00391-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993
- Williamsburg Conference on Biological and Immunological Treatments for Cancer, 1992JNCI Journal of the National Cancer Institute, 1993
- Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivoNature, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992
- Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of ProteinsEndocrine Reviews, 1992
- Vascular permeability factor: A unique regulator of blood vessel functionJournal of Cellular Biochemistry, 1991
- Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.The Journal of Experimental Medicine, 1991
- Monoclonal Antibodies in Diagnosis and TherapyScience, 1991
- Haemodynamic and Transport Barriers to the Treatment of Solid TumoursInternational Journal of Radiation Biology, 1991